The problem the coronary circulation is solving
The myocardium is an “oxygen-hungry” organ with very high resting O₂ extraction (~70%). That means when the heart needs more oxygen (exercise, pain, tachycardia, inotropes), it can’t meaningfully extract much more from each mL of blood.
So the only reliable way to increase oxygen delivery is:
Increase coronary blood flow (and/or raise arterial O₂ content)
At rest, CBF is about 250 mL/min (~5% of cardiac output) and can increase up to ~5× with high demand.
What drives coronary flow?
Flow ≈ Pressure gradient / Resistance
So to increase coronary blood flow, we can either:
- Increase the pressure gradient (coronary perfusion pressure), or
- Decrease coronary arterial resistance.
To increase the pressure gradient, it is helpful to remember the equation determining CPP. Remember that for the left coronary circulation, the key pressure gradient is mainly in diastole:
CPP (coronary perfusion pressure) ≈ Aortic diastolic pressure − LVEDP
So anything that:
lowers aortic diastolic pressure (hypotension, vasodilation, severe AR)
raises LVEDP (LV failure, fluid overload, high PEEP, poor diastolic relaxation, mitral regurg)
will reduce the driving pressure for perfusion and reduce coronary blood flow.
Resistance is mostly determined at the level of small arteries/arterioles, where tone is actively regulated.
Mechanisms that regulate coronary resistance
Metabolic regulation (the primary mechanism)
This is the “autopilot” that matches flow to demand.
When myocardial work rises:
ATP use rises → ATP falls, AMP rises
Breakdown of adenine nucleotides leads to release of adenosine
Adenosine opens ATP-sensitive K⁺ channels → smooth muscle hyperpolarisation → arteriolar vasodilation
Plus additional local vasodilators rise with metabolism: K⁺, CO₂, H⁺, lactate, prostaglandins
In summary:
Coronary arterioles are tuned to myocardial oxygen demand, not just pressure.
If demand rises (tachycardia/inotropes), metabolic vasodilation usually overrides competing vasoconstrictor influences.
Autoregulation (pressure buffering)
Within a range of coronary perfusion pressures (classically around 60–180 mmHg), the heart can keep flow relatively constant.
Main mechanism is the myogenic response:
vessel stretch due to hypertension → coronary constriction
less stretch due to hypotension → coronary relaxation to decrease resistance and increase flow
In summary:
Below the lower limit, flow becomes pressure-dependent: hypotension can cause ischaemia even if coronaries are normal.
In diseased coronaries (stenoses), distal beds may already be maximally dilated at rest → reduced ability to autoregulate and augment flow.
Endothelial regulation
The endothelium senses shear stress and chemical signals and releases vasoactive mediators:
Vasodilators
Nitric oxide (NO): key relaxant; released with shear stress and certain agonists
Prostacyclin (PGI₂): vasodilation + anti-platelet effects
Vasoconstrictors
Endothelin-1: potent constrictor (especially prominent in endothelial dysfunction)
Thromboxane A₂: vasoconstrictor + platelet activator (increased with endothelial damage/platelet activation)
In summary:
Endothelial dysfunction (atherosclerosis, diabetes, smoking) shifts balance toward constriction/thrombosis → worse flow regulation and propensity to spasm/thrombosis.
Autonomic control
Direct effects on coronary vessels exist but are usually smaller than metabolic control.
Sympathetic
Direct α₁ effect: vasoconstriction (would reduce flow)
But sympathetic stimulation also increases HR + contractility → ↑ myocardial demand → ↑ metabolites/adenosine → dominant vasodilation
Net effect in most situations: increased coronary flow, driven indirectly by demand.
Parasympathetic
Weak direct vasodilation
Big indirect effect is usually reducing HR (and therefore demand)
Mechanical/physical factors
The LV myocardium compresses its own microcirculation during systole. So:
Left coronary flow occurs predominantly in diastole
Right coronary flow is less diastole-dependent (lower RV pressures), but LV is the classic exam focus
Tachycardia: why it’s so dangerous for the myocardium
Tachycardia:
Shortens diastole disproportionately → less time to perfuse LV
Increases oxygen demand (more work, more wall stress, higher inotropy often)
Can increase LVEDP (especially if diastolic filling becomes impaired) → lowers CPP
So it hits supply and demand in the wrong direction.
Blood viscosity and oxygen content
Higher haematocrit → higher viscosity → higher resistance → can reduce flow
Anaemia → lower arterial oxygen content even if flow is fine → supply problem
In summary:
Anaemia and tachycardia are a nasty combination in coronary disease: reduced O₂ content + reduced diastolic time + increased demand.
Pharmacological manipulation (what we can modify)
Nitrates
Vasodilate (including large epicardial coronaries)
Reduce demand by ↓ preload (and often ↓ afterload)
Improve subendocardial perfusion by reducing LV volume/wall stress and LVEDP (helping CPP)
β-blockers
↓ HR → prolong diastole, improving LV perfusion
↓ contractility → ↓ demand
Particularly useful when tachycardia is the main driver of ischaemia
Calcium channel blockers
Coronary arteriolar vasodilation (useful in vasospasm)
Some also ↓ HR/contractility depending on class (non-dihydropyridines)
K⁺ channel openers (e.g., nicorandil)
Smooth muscle hyperpolarisation → vasodilation (conceptually similar pathway to metabolic KATP effects)
To summarise
The 3 main levers for myocardial ischaemia are:
CPP (pressure gradient): keep aortic diastolic pressure up and LVEDP down
Diastolic time: avoid/treat tachycardia
O₂ content: avoid significant anaemia/hypoxaemia
For example
Hypotension at induction → ↓ aortic diastolic pressure → ↓ CPP → reduced LV perfusion
Light anaesthesia/pain → causes tachycardia → ↓ diastolic time + ↑ demand → can trigger ischaemia in risk patients
LV failure/poor compliance → ↑ LVEDP → ↓ CPP, especially risky if combined with low diastolic pressure